Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

SQI Diagnostics Inc V.SQD.H

Alternate Symbol(s):  SQIDF

SQI Diagnostics Inc. is a Canada-based company that is focused on lung health. The Company is engaged in the development and manufacturing of respiratory health and precision medicine tests that run on its fully automated systems. Its clinical solutions include Rapid Acute Lung Injury Diagnostic (RALI-Dx), lung transplant diagnostics, COVID-19 testing and surveillance testing solutions. Its RALI-Dx IL-6 Severity Triage Test and the RALI-fast IL-6 Severity Triage point of care (POC) Test each help clinicians identify which patients with SARS-CoV-2 are predicted to have a severe inflammatory response and should or should not be admitted to the hospital. Its RALI-Dx delivers results from the lab in less than an hour while RALI-fast delivers results at the patient point-of-care in about 15 minutes. The Company’s TORdx LUNG Test measures inflammation at the molecular level to assess the health of the donor lung. The Company is also focused on its organ transplant pipeline of products.


TSXV:SQD.H - Post by User

Post by MasterTigeron Jun 17, 2023 10:17pm
278 Views
Post# 35502114

Pivot Financial

Pivot FinancialIn February 2022, Pivot Financial assisted SQI Diagnostics Inc. (“SQI”) in the purchase of Precision Biomonitoring (“PBI”) by agenting a $7,500,000 two (2) month senior secured bridge facility.  SQI (TSXV: SQD) is a leader in the science of lung health that develops and manufactures respiratory health and precision medical tests that run on SQI’s fully automated systems.  The assets acquired from PBI related to its human diagnostic COVID – 19 PCR molecular testing business.  The merger of the two business resulted in significant synergies including cross selling opportunities between their respective client bases. 

-------------

The decision to issue the notice was made solely by Pivot, as the insider indebtedness is subordinate to Pivot's interest in the indebtedness and Pivot retained all decision-making authority pursuant to the terms of the participation agreements.

-------------

Pivot helped with the aquisition of PBI in 2022 and now they want everything? Hopefully the judge will only give them the PBI assets only and we take the other assets and intelectual properties to licence them out. New business model.
Lets Go.

No quiting, keep fighting!
<< Previous
Bullboard Posts
Next >>